scholarly article | Q13442814 |
P356 | DOI | 10.1002/CCD.25189 |
P698 | PubMed publication ID | 24030753 |
P50 | author | Franz-Josef Neumann | Q1308604 |
Adnan Kastrati | Q63253283 | ||
Karl-Ludwig Laugwitz | Q63253454 | ||
Stefanie Schulz | Q38590171 | ||
Robert A Byrne | Q60607602 | ||
P2093 | author name string | Gert Richardt | |
Salvatore Cassese | |||
Gjin Ndrepepa | |||
Massimiliano Fusaro | |||
P2860 | cites work | Effects of age on the quality of care provided to older patients with acute myocardial infarction | Q28195627 |
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel | Q33358562 | ||
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail | Q34316739 | ||
Urban and rural dimensions of global population aging: an overview | Q34692807 | ||
The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction | Q36162429 | ||
Clinical end points in coronary stent trials: a case for standardized definitions | Q36807166 | ||
Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients | Q37538067 | ||
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium | Q37889006 | ||
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial | Q38408523 | ||
ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention | Q38500578 | ||
A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. | Q40475543 | ||
Predictors of hospital mortality in the global registry of acute coronary events | Q42611826 | ||
Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome | Q43287862 | ||
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention | Q44619428 | ||
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes | Q45003891 | ||
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel | Q45143057 | ||
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention | Q46429322 | ||
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point | Q46750174 | ||
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). | Q47438826 | ||
Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. | Q50491796 | ||
Association between bleeding severity and long-term mortality in patients experiencing vascular complications after percutaneous coronary intervention. | Q51407317 | ||
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. | Q55055193 | ||
P433 | issue | 2 | |
P304 | page(s) | 182-189 | |
P577 | publication date | 2013-10-19 | |
P1433 | published in | Catheterization and Cardiovascular Interventions | Q2352240 |
P1476 | title | Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age. | |
P478 | volume | 83 |
Q93379484 | Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare |
Q56384060 | Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease |
Q38689160 | Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes. |
Q53335552 | Favorable outcomes in octogenarians treated with bioresorbable polymer drug-eluting stent. |
Q47869639 | Inflammation and hemostasis in older octogenarians: implication in 5-year survival. |
Q64277042 | Invasive strategy in elderly patients with acute coronary syndrome in 2018: close to the truth? |
Q40478828 | Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. |
Q41557516 | Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention |
Q41265471 | Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly |
Search more.